1. Home
  2. JAMF vs VRNA Comparison

JAMF vs VRNA Comparison

Compare JAMF & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAMF
  • VRNA
  • Stock Information
  • Founded
  • JAMF 2002
  • VRNA 2005
  • Country
  • JAMF United States
  • VRNA United Kingdom
  • Employees
  • JAMF N/A
  • VRNA N/A
  • Industry
  • JAMF Computer Software: Prepackaged Software
  • VRNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAMF Technology
  • VRNA Health Care
  • Exchange
  • JAMF Nasdaq
  • VRNA Nasdaq
  • Market Cap
  • JAMF 1.9B
  • VRNA 2.2B
  • IPO Year
  • JAMF 2020
  • VRNA 2017
  • Fundamental
  • Price
  • JAMF $14.84
  • VRNA $35.66
  • Analyst Decision
  • JAMF Buy
  • VRNA Strong Buy
  • Analyst Count
  • JAMF 7
  • VRNA 6
  • Target Price
  • JAMF $23.00
  • VRNA $43.83
  • AVG Volume (30 Days)
  • JAMF 491.1K
  • VRNA 1.1M
  • Earning Date
  • JAMF 11-07-2024
  • VRNA 11-04-2024
  • Dividend Yield
  • JAMF N/A
  • VRNA N/A
  • EPS Growth
  • JAMF N/A
  • VRNA N/A
  • EPS
  • JAMF N/A
  • VRNA N/A
  • Revenue
  • JAMF $615,070,000.00
  • VRNA $5,624,000.00
  • Revenue This Year
  • JAMF $13.65
  • VRNA N/A
  • Revenue Next Year
  • JAMF $12.96
  • VRNA $554.09
  • P/E Ratio
  • JAMF N/A
  • VRNA N/A
  • Revenue Growth
  • JAMF 13.85
  • VRNA 1127.95
  • 52 Week Low
  • JAMF $14.47
  • VRNA $11.39
  • 52 Week High
  • JAMF $21.41
  • VRNA $40.13
  • Technical
  • Relative Strength Index (RSI)
  • JAMF 29.99
  • VRNA 51.76
  • Support Level
  • JAMF $16.48
  • VRNA $36.49
  • Resistance Level
  • JAMF $15.83
  • VRNA $40.13
  • Average True Range (ATR)
  • JAMF 0.63
  • VRNA 2.01
  • MACD
  • JAMF -0.19
  • VRNA -0.30
  • Stochastic Oscillator
  • JAMF 10.48
  • VRNA 47.60

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Share on Social Networks: